Selected Grants
Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients with Motor Complications
Clinical TrialPrincipal Investigator · Awarded by Cerevance Beta, Inc. · 2024 - 2027A Randomized, Double-Blind, Placebo-Controlled Trial of CVN424 in Early Parkinson's Disease
Clinical TrialPrincipal Investigator · Awarded by Cerevance Beta, Inc. · 2023 - 2025External Relationships
- Guidepoint Global
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.